ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pfizer Granted FDA Breakthrough Therapy for 20-Valent Pneumococcal Conjugate Vaccine
September 21, 2018Pfizer announced its 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for the prevention of invasive disease and pneumonia caused by Streptoc
Pharma Sources Insight January 2025
